Navigation
Dr. Chahinez Houacine

Dr. Chahinez Houacine

Teaching fellow in Biosciences and Chemistry

School of Pharmacy and Biomedical Sciences

Maudland Building MB023

+44 (0) 1772 89 5846

chouacine1@uclan.ac.uk

Subject Areas: Pharmacy and Pharmacology, Education, Biosciences and Chemistry

Chahinez is a currently working as a Teaching Fellow in Biosciences and Chemistry at the School of Pharmacy and Biomedical Sciences. She has a PhD in Pharmaceutical Formulations from UCLan, UK in addition to an MSc in Clinical Pharmacy and pharmacology (2013-2014) from UMST, Sudan.

Previously, she worked as a Postgraduate Lecturer in Cosmetic and Pharmacotherapy. Her current research focuses upon the development of lipid-based drug delivery systems for novel chemotherapeutic agents in the treatment of cancers.

Full Profile

Dr. Chahinez Houacine is currently employed as a Teaching Fellow in Biosciences and Chemistry, with a strong background in pharmaceutics and clinical pharmacology. Previous employment includes postgraduate lecturing in Cosmetics and Pharmacotherapy; as well as demonstrating on a number of undergraduate pharmacy modules.

She attained her PhD in Pharmaceutical formulations from UCLan in 2017 and MSc in Clinical pharmacy in 2013 following graduation as a pharmacist (BPharm) in 2011 both from the University of Sudan.

Her research is focused around Lipid-based drug delivery systems in cancerous growths, particularly modified nanostructured lipid particles with novel chemotherapeutic agents. She is interested in biocompatible and biodegradable formulations in drug delivery.

Qualifications:

  • PhD in Pharmaceutical drug delivery, University of Central Lancashire (UCLan), 2017
  • MSc in Clinical Pharmacology, University of Medical Sciences and Technology(UMST), (Khartoum) Sudan, 2013
  • BSc in Pharmacy, University of Medical Sciences and Technology(UMST), (Khartoum) Sudan, 2011  

Conferences:

  • Presented a poster at the 42nd CRS ANNUAL MEETING & EXPOSITION on 26th - 29th  July 2015 entitled: Quality by Design Approach for formulation of Resveratrol lipid nanoparticles: Multivariate design for optimizing process and product parameters  
     
  • Presented in 3 Minute Thesis competition at The University of Central Lancashire on 8th December 2015 entitled: DESIGN AND EVALUATION OF RESVERATROL LIPID NANOPARTICLES FOR CANCER CHEMOTHERAPY  
     
  • Presented at the BTNW held in Preston on the 10th/11th of December 2015 entitled: QUALITY BY DESING APPROACH FOR FORMUALTION OF ANTICANCER RESVERATROL LIPID NANOPARTICLES.  
     
  • Presented at the Functional nanomaterials in industrial applications: Academic-Industry meet 29th -31st March 2016. UCLan. UK. entitled: Resveratrol-Nanostructured Lipid Carriers: Effect of Liquid Lipids and Surfactants on Particle Size and Stability
     
  • Presented at the 6th FIP Pharmaceutical Sciences World Congress. Stockholm, Sweden entitled:  Nano-Resveratrol: The Wonder Anticancer Drug Delivery System”.

Publications

  • CHIYAD, M. A., HOUACINE, C., MAHMOOD, H. & ALI, H. M. 2016. ” Adherence of Medical Practitioners to the National Malaria Protocol among Primary Health Care Centres in Khartoum Locality”. World Journal of Pharmacy and Pharmaceutical Sciences, 5, 1652-1658.
     
  • HOUACINE, C., KHAN, I., YOUSAF, S., PAWAR, S., HOUACINE, N. & ELKHAWAD, A. O. 2015. ”Investigation of the Rational Medicines Use among Pregnant Women in Sudan Hospital”. World Journal of Pharmacy and Pharmaceutical Sciences, 4, 350-360.
     
  • KHAN, I., YOUSAF, S., ABDALLAH, B., HOUACINE, C. & AHMED, W. 2015. ”Speed, sensitivity and reproducibility: High Performance Liquid Chromatography (HPLC) at the forefront of chemical analysis”. Journal of Advanced Pharmaceutical Research, 6, 40-47
     
  • HOUACINE, C., ELKHAWAD, A. O. & AYOUB, M. H. 2013. ”A comparative study on the anti-diabetic activity of extracts of some Algerian and Sudanese plants”. Global Journal of Hematology and Endocrinology, 1, 118-121.

Research Activities

  • Pharmaceutical Drug Delivery Systems, Solid lipid nanoparticles, Nanostructured Lipid Carriers, liposomes
  • Nano-formulations
  • Lipid-based formulations and their effect in in-vivo and in-vitro studies
  • Scale up of Advanced Drug Delivery systems

Projects

  • Anticancer Drug Delivery systems including Solid Lipid nanoparticles, Nanostructured Lipid carrier and liposomal formulations.
  • Testing the formulated nanoparticles on various cell lines employing multiple cell culture studies. 

Teaching activities

Pharmacology, Chemistry and Biosciences

Membership

Associate Fellow of the Higher Education Academy, 2017